Contraceptive Technology Update – September 1, 2004
September 1, 2004
View Archives Issues
-
New labeling for the Pill: Will it change how you prescribe oral contraceptives?
When it comes to using combined oral contraceptives (OCs), clinicians and patients look to drug package labeling for the most current information on how the Pill may be safely and effectively used. -
Mandatory EC provision raises debate in Alabama
Is providing emergency contraception (EC) a problem for clinicians in your facility? Since January 2004, eight nurses within the Alabama Department of Public Health system have retired or resigned with letters of resignation that listed dispensing EC as at least one of their reasons for leaving. -
And then there was one: Barr withdraws Preven
Rewind to September 1998. Gynétics of Somerville, NJ, introduces the Preven Emergency Contraceptive Kit, the first product for emergency contraception (EC) approved by the Food and Drug Administration (FDA). Now fast-forward six years to the present. The drugs new owner, Barr Pharmaceuticals of Pomona, NY, announces that it will no longer manufacture the product. -
Plan B seeks OTC status for women ages 16-plus
The emergency contraceptive (EC) Plan B may be available over the counter (OTC) to women ages 16 and older if the Food and Drug Administration (FDA) approves Pomona, NY-based Barr Pharmaceuticals revised request for OTC status. -
New methods may rate, but are they covered?
A just-issued nationwide survey shows that newer reproductive health options such as the contraceptive patch, the contraceptive vaginal ring, and hysteroscopic sterilization are poorly covered by insurance companies when compared to more traditional methods such as the birth control pill. -
New microbicides enter trials in United States
Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials this fall, with research to focus on the safety and acceptability in healthy women and women infected with HIV. -
Give teens more info to bridge information gap
Your next patient is a 17-year-old female who is interested in contraception. While she says she knows about the contraceptive patch and the vaginal ring, when you ask her about their effectiveness in preventing sexually transmitted diseases (STDs), she gives you a puzzled look.